Alice Blue - 20 years of trust
    • ANT APP
    • ANT WEB
    • 1LyAlgos
    • 1lyOptions
    • TradingView
    • MTF
    • Insurance
    • IPO
    • Stocks
    • Mutual Funds
  • Partner with us
  • Trade School
  • Pricing

    • Pricing

    About Us

    • About Us

    Calculator

    • Calculators
    • Brokerage Calculator
    • MTF Calculator

    Resources

    • Blog
    • Webinars
    • Videos (YouTube)

    Updates

    • News
    • Trading Holidays
    • Cares
    • Media Coverage
    • Disclosures

    Support

    • Support
    • Refer & Earn
    CommunityCareers
Login

    Start Investing in Stocks₹0 Account Opening

    +91
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsVodafone IdeaPC JewellerYes BankBelrise IndustriDhanlaxmi BankMoneyviewTata Silver ETFTata Gold ETFInox WindNippon I SilverV2 RetailPunjab Natl.BankTata Motors PVehNip. India GoldITCYatra OnlineOla ElectricSuzlon EnergySyncom Formul.
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?
    Shares
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsVodafone IdeaPC JewellerYes BankBelrise IndustriDhanlaxmi BankMoneyviewTata Silver ETFTata Gold ETFInox WindNippon I SilverV2 RetailPunjab Natl.BankTata Motors PVehNip. India GoldITCYatra OnlineOla ElectricSuzlon EnergySyncom Formul.
    Indices
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    F&O
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Mutual Funds
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    Calculators
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    IPO
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?

    Company
    • About Us
    • Work with Us
    • Terms and Conditions
    • EKYC Guidelines
    • Contact Us
    • Cares
    Apps and Products
    • ANT APP
    • ANT WEB
    • 1LYOptions
    • Trade School
    • TradingView
    • 1LyAlgos
    Calculators
    • Calculators
    • SIP Calculator
    • Mutual Funds Return Calculator
    • Brokerage Calculator
    • RMS Live Updates
    • Term Coverage Calculator
    Important Links
    • Pricing
    • KYC Tracker
    • Market News
    • Global Indices
    • Gold Rate
    • Silver Rate
    • Trading Holidays

    Alice Blue
    3rd Floor, M.R.B.Arcade, No. 153/2,
    Bagalur Main Rd, Dwarka Nagar,
    Yelahanka, Bengaluru, Karnataka
    560063
    FacebookLinkedInX (Twitter)YouTubeInstagramWhatsapp

    ISO 27001:2022 Alice Blue is Certified Information Security Management System (ISMS)

    ISO 22301:2019 Alice Blue is Certified Business Continuity Management System (BCMS)

    DownloadsCircularsBank DetailsLearn
    Trade on TradingViewGet it on Google PlayDownload on the App Store

    Attention Investors!
    Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.

    Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from the depository on your email id and/or mobile number to create a pledge. Pay 20% upfront margin of the transaction early to trade in the cash market segment. Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020, and NSE/INSP/45534 dated August 31, 2020, and other guidelines issued from time to time in this regard. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

    Corporate Office: No. 153/2, 3rd Floor, M.R.B.Arcade, Bagalur Main Road, Dwaraka Nagar, Yelahanka, Bengaluru – 560 063, Karnataka.
    Registered Office: Old No.56/2 ,New No.58, LIC Nagar, Vinayagar Kovil Street, Erode -8,Tamil Nadu– 638002.
    Alice Blue Financial Services (P) Ltd : NSE EQ | NSE FO | NSE CDS-90112 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : BSE EQ | BSE FO | BSE CD-6670 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : CDSL DP ID 12085300 DP SEBI REG : IN-DP-364-2018
    Alice Blue Financial Services (P) Ltd : MCX-56710 SEBI REG : INZ000156038

    COMPLIANCE OFFICER: SARAVANAN R | Mobile No: +91 91872 10670 | Email:[email protected]

    We hereby declare that we are doing PRO trading

    Procedure to file a complaint on SEBI SCORES / SMART ODR : Register on SEBI SCORES 2.0 / SMART ODR. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

    Click on the provided link to learn about the process for submitting a complaint on the ODR platform for resolving investor grievances. ODR Circular

    Investment in securities markets are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit.

    For queries regarding account opening or activation, email to accountactivation@aliceblueindia.com and for fund updates, email to funds@aliceblueindia.com

    Disclaimer: Attention investors:1) Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. 2) Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. 3) Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. 4) For demat and trading account closure with AliceBlue, kindly visit https://aliceblueonline.com/support/closure-freezing-reactivation or “ANT APPLICATION” under your profile and click on Settings -> Account Closure section -> Initiate account closure.

    No need to issue cheques by investors while subscribing to an IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor’s account.

    Investors are requested to note that Alice Blue Financial Services Private Limited is permitted to receive money from investor through designated bank accounts only named as Up streaming Client Nodal Bank Account (USCNBA). Alice Blue Financial Services Private Limited is also required to disclose these USCNB accounts to Stock Exchange. Hence, you are requested to use following USCNB accounts only for the purpose of dealings in your trading account with us. The details of these USCNB accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker. Bank Details (Valid UPI FAQ).

    DND PolicyInvestor CharterLegal DocumentationPrivacy policyFeedbackAnnual ReturnsAdvisory for InvestorsE-votingMandatory Member Details

    Performance

    Historical price movement and trading activity

    Trading Data

    Today's High

    20.7

    Today's Low

    20.01

    Open

    20.3

    Previous Close

    20.29

    Volume

    7116766

    Total Traded Value High

    144838539.23

    Technicals

    Price-based indicators and levels

    Indicators

    IndicatorValueSignal
    Relative Strength Index (RSI)+47.41Neutral
    MACD-0.26Bearish

    Support and Resistance Levels

    R321.35
    R221.02
    R120.66
    S119.97
    S219.64
    S319.28

    Moving Averages

    PeriodSMAEMA
    20D Moving Average20.5620.61
    50D Moving Average21.1220.21
    200D Moving Average15.6217.23
    Syncom Formulations (India) Ltd

    Syncom Formulations (India) Ltd

    NSE: SYNCOMF | BSE: 524470
    ₹21.35+1.06 (5.22%)
    BuySell

    News

    Syncom Formulations to review financial results at board meeting on November 13

    4 Nov 2026

    Syncom Formulations (India) Limited will hold a meeting of its Board of Directors on November 13, 2026, at 3:00 P.M. (IST) to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2026, and to take on record the standalone and consolidated limited review report by auditors for the same period, along with other matters including the unaudited statement of assets and liabilities and statement of cash flow for the half year ended September 30, 2026.

    SYNCOM Formulations confirms regulatory compliance filing with Indian stock exchanges

    8 Oct 2026

    SYNCOM Formulations (India) Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Limited for compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by its Registrar and Share Transfer Agent, Ankit Consultancy Pvt. Ltd.

    Syncom Formulations shareholders approved a Rs 0.10 per share dividend for FY26

    1 Oct 2026

    Syncom Formulations (India) Limited announced that its members approved a final dividend of Rs 0.10 (10%) per equity share on 94,00,00,000 equity shares for the financial year 2025-26 at its 38th Annual General Meeting held on Wednesday, September 30, 2026.

    Syncom Formulations shareholders approve Bankdas' appointments and Jindal's director role

    1 Oct 2026

    Syncom Formulations (India) Limited announced that its shareholders approved the appointment of Rahul Vijay Bankda as Managing Director, effective August 12, 2026, and Rinki Ankit Bankda as Whole Time Director, also effective August 12, 2026. Additionally, the company re-appointed Ruchi Jindal as an Independent Woman Director for a second five-year term, effective June 28, 2027.

    Syncom Formulators' promoters forgo Rs 47.5 crore dividend payout for fiscal 2026

    26 Sept 2026

    Syncom Formulations (India) Limited informed the Bombay Stock Exchange and National Stock Exchange that its Promoters and Promoter Group have voluntarily waived their entitlement to receive the final dividend of Rs 0.10 per equity share for the financial year ended March 31, 2026, representing a total of Rs 4,75,34,759.90, out of the company’s 94,00,00,000 outstanding equity shares, of which 47,53,47,599 shares are held by the Promoters and Promoter Group.

    Showing 1–5 of 11

    Insider Activity

    Kedarmal Shankarlal BankdaPromoter & Director
    Acquired
    2731470
    Shares Worth
    ₹0
    Reported On16 Jun 2023
    ModeOff Market
    Asha BankdaPromoter Group
    Acquired
    13500000
    Shares Worth
    ₹3,41,55,000
    Reported On9 Jun 2022
    ModeConversion of security
    Vimla BankdaPromoter Group
    Acquired
    40047000
    Shares Worth
    ₹10,13,18,910
    Reported On9 Jun 2022
    ModeConversion of security
    Kedarmal Shankarlal BankdaPromoter
    Acquired
    24000000
    Shares Worth
    ₹6,07,20,000
    Reported On9 Jun 2022
    ModeConversion of security
    Asha Vijay BankdaPromoter Group
    Acquired
    32500000
    Shares Worth
    ₹8,22,25,000
    Reported On28 Feb 2022
    ModeConversion of security
    Trade now

    Overview

    Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE / BSE

    Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992.. The Company is considered as a Global Pharmaceutical Company in delivering innovative medicines and vaccines that address the evolving healthcare needs of India and improve the quality of life for millions in the country. Products include tablets, capsules, injectables, sprays, ointments, creams and liquids, to serve diverse markets effectively. Currently, the Company manufactures and markets more than 400 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.'89. Promoters are Kedarmal Bankda, Vijay Kumar Bankda and Ajay Kumar Bankda. In addition to pharmaceutical formulations in the form of tablets, capsules, liquids and dry powders, the company also manufactures injectibles and ear/eye drops on a loan licence basis. In 1994, the company undertook an expansion programme of setting up a new plant for manufacturing pharmaceutical formulations at Pithampur, Madhya Pradesh. The project which was financed through a public issue made in Jan.'94 was completed in 1995. During the year 1997-98, the Company has further diversified into Ethical Operations by introducing the range of prescription formulations. During the year 1998-99 there has been huge expansion of installed capacity and production base. Further the company plans introduction of products in the generic, OTC and Ethical Divisions. The export earnings have also registered a growth of more than 100%. During the year 1999-2000, the company and its associates have received export orders worth Rs.700.00 lacs against advance payment and hence better turnover is expected during the year. The company presently exports goods to Guine, Ghana, Kenya, Tanzania, Nigeria in Africa, Azberjan, Nepal and Srilanka in Asia. The company has been approved as a supplier to Central ESI Hospitals and registration of defence services is in its final stages, as a result of which will generate substantial sales volume. Keeping in view the shifting consumer preferenes for the use of herbal products, the company is aggressively manufacturing and marketing its herbal products like Edicare, Attom Megacaps, Ecziguard and Yas antacid salt. The modernisation of injectable section by putting Tunnel System and other modern equipments and expansion of tablet department by putting high speed mega press machines was completed in 2002. The Company carried out an expansion program of the installed capacities of its manufacturing unit at Pithampur, Dist. Dhar to increase the capacity of tablet section by 35% and also doubling of the capacity of capsule section. Capacity of packing section was increased in line with the increase in capacity of the said formulation sections. The expansion cum modernization program was implemented at a total cost of Rs. 1.34 crore out of which the major expenditure was incurred in 2002-03. The expanded capacities were made available for production from May, 2003. In 2007, the Company launched a new division 'Cratus Life Care' to expand its operations. The expansion cum modernization project at Pithampur unit was completed with the total investment costing Rs 15.17 Crore during the year 2007-08. The Company raised long term financial resources by way of preference issuance of 3,10,000 equity shares of Rs.10 each at a premium of Rs.36 per share on 29 March, 2008 to the promoters of the Company and the said Equity got listed with the BSE in 2008. In 2023-24, Company has expanded the business by increasing the overall production capacity of Injectable capacity from 200 Lakhs to 300 Lakhs per annum. The Company has altered a change in business to carry on manufacturing and trading of nutraceuticals, dietary supplements, health supplements, functional foods, herbal and ayurvedic preparations, vitamins, minerals, proteins, antioxidants, natural extracts, organic and wellness products, and all related healthcare and nutrition-based goods and Real Estate Business respectively. and insertion of the Article authorising Board of Directors related to electricity generation and related activities of the company in 2025-26.

    Fundamentals

    Financial strength and ownership structure

    Valuation & Ratios

    Market Capitalisation

    ₹968.20

    Price to Book (PB)

    2.34

    Price to Earnings (PE)

    12.72

    Return on Equity (ROE)

    20.19%

    Earnings Per Share (EPS)

    0.81

    Dividend Yield

    0.97%

    Financial Performance

    65.14
    74.57
    87.26
    102.31
    127.53
    148.88
    116.90
    121.72
    115.14
    135.41
    125.53
    142.14
    Dec
    '23
    Mar
    '24
    Jun
    '24
    Sep
    '24
    Dec
    '24
    Mar
    '25
    Jun
    '25
    Sep
    '25
    Dec
    '25
    Mar
    '26
    Jun
    '26
    Sep
    '26

    Shareholding Pattern

    50.57%
    50.57%
    50.57%
    50.57%
    Dec
    '25
    Mar
    '26
    Jun
    '26
    Sep
    '26